Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal

Medicine & Life Sciences

1. Radiotherapy 100%
2. Head and Neck Neoplasms 59%
3. India 36%
4. Radiation 36%
5. Neoplasms 34%
6. Uterine Cervical Neoplasms 30%
7. Breast Neoplasms 27%
8. Intensity-Modulated Radiotherapy 25%
9. Chemoradiotherapy 25%
10. Stomatitis 23%
11. Drug Therapy 19%
12. Brachytherapy 19%
13. Randomized Controlled Trials 17%
14. Therapeutics 14%
15. Mouth Neoplasms 13%
16. Carcinoma 13%
17. Non-Hodgkin's Lymphoma 13%
18. Squamous Cell Carcinoma of Head and Neck 13%
19. Neoplasm Metastasis 13%
20. Quality of Life 12%
21. Cervix Uteri 12%
22. Neck 12%
23. Head 11%
24. Cisplatin 11%
25. Survival 11%
26. Squamous Cell Carcinoma 10%
27. Low-Level Light Therapy 9%
28. Breast 9%
29. Pelvis 9%
30. Nepal 9%
31. Systematic Reviews 9%
32. Mucositis 9%
33. Glutathione 8%
34. Conformal Radiotherapy 8%
35. Tertiary Care Centers 8%
36. Organs at Risk 8%
37. Neon 8%
38. Retrospective Studies 8%
39. Tomography 8%
40. Deglutition Disorders 8%
41. Pandemics 8%
42. Pain 7%
43. Deferiprone 7%
44. Ionizing Radiation 7%
45. Syzygium 7%
46. DNA Damage 7%
47. Planning Techniques 7%
48. Vincristine 7%
49. Liquid Biopsy 7%
50. Spermatozoa 6%
51. Xerostomia 6%
52. Fatigue 6%
53. Urinary Bladder 6%
54. Lasers 6%
55. MicroRNAs 6%
56. Palliative Care 6%
57. Laser Therapy 6%
58. Exercise 6%
59. Lymphoma 6%
60. Gas Lasers 6%
61. Skin 5%
62. Radiation Oncology 5%
63. Semen 5%
64. Cohort Studies 5%
65. Lymphoma, Large B-Cell, Diffuse 5%
66. Esophageal Neoplasms 5%
67. Equipment and Supplies 5%
68. Occupational Groups 5%
69. Cancer Survivors 5%
70. Sulfhydryl Compounds 5%
71. Antioxidants 5%
72. Esophagus 5%
73. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5%
74. Rectal Neoplasms 5%
75. Morbidity 5%
76. Recurrence 5%